3644 results for «2683»

Filter By

3644 results

IVUS and NIRS imaging: a pathway to improve outcomes in stable and acute coronary syndromes

19 May 2026 – From EuroPCR 2026

IVUS-guided PCI is well established in complex coronary interventions, but combining it with near-infrared spectroscopy (NIRS) is opening a new dimension by linking vessel geometry with plaque biology.

This EuroPCR 2026session explores how IVUS-NIRS imaging improves PCI planning and risk stratification in both stable and acute coronary...

IVUS and NIRS imaging: a pathway to improve outcomes in stable and acute coronary syndromes

Artificial intelligence-powered precision: CT-guided PCI and the future of image-guided therapy

19 May 2026 – From EuroPCR 2026

Image-guided PCI is entering a new era, driven by artificial intelligence and advanced CT technologies that are reshaping how coronary interventions are planned and performed.

This EuroPCR 2026 session explores the integration of photon-counting CT into PCI workflows, highlighting its improved spatial resolution, enhanced plaque characterisation and...

Artificial intelligence-powered precision: CT-guided PCI and the future of image-guided therapy

Beyond the angiogram: contemporary management of STEMI

19 May 2026 – From EuroPCR 2026

This session provides an in-depth review of complex STEMI cases from diverse clinical settings, emphasizing optimisation of primary PCI strategies, complication management, and individualised antithrombotic therapy. Real-world cases from Albania, Macedonia, and Slovakia illustrate diagnostic challenges and therapeutic decision-making to improve patient outcomes.

DCB: does coating morphology matter for distal embolisation and clinical outcomes?

20 May 2026 – From EuroPCR 2026

Drug-coated balloon (DCB) therapy continues to evolve, with increasing attention on how coating design may influence drug transfer, vessel response and downstream clinical outcomes.

This EuroPCR 2026 session examines the role of coating morphology, comparing amorphous and crystalline technologies and their implications for drug delivery efficiency and...

DCB: does coating morphology matter for distal embolisation and clinical outcomes?

TAVI complications and management strategies

19 May 2026 – From EuroPCR 2026

Gain comprehensive knowledge on anticipating, identifying, and managing complications during transcatheter aortic valve implantation (TAVI). Through complex international case studies—including transaxillary Navitor implantation and bicuspid aortic valve challenges—this session highlights key strategies to improve procedural safety and outcomes.

MagicTouch sirolimus-coated balloon for coronary artery disease and peripheral artery disease treatment: where evidence meets experience

20 May 2026 – From EuroPCR 2026

This session examines the clinical evidence and experiential insights regarding the MagicTouch sirolimus-coated balloon (SCB) for treating coronary and peripheral artery disease. It reviews long-term comparative data versus paclitaxel-coated balloons, application techniques, integration into current practices, and findings from major trials such as SIRONA and SIMPLE-DM,...

MagicTouch sirolimus-coated balloon for coronary artery disease and peripheral artery disease treatment: where evidence meets experience

Angiography-based physiology: time to change your routine clinical practice?

20 May 2026 – From EuroPCR 2026

This session offers a critical appraisal of angiography-based physiology, with a focus on virtual fractional flow reserve (vFFR) technology. It reviews the latest clinical evidence, including insights from the FAST study programme and the FAST III randomised controlled trial. Gain a clear understanding of current guideline...

Angiography-based physiology: time to change your routine clinical practice?

Beyond visualisation: the value and future of 4D intracardiac echocardiography in tricuspid repair and replacement

20 May 2026 – From EuroPCR 2026

Explore the transformative role of 4D intracardiac echocardiography in guiding tricuspid edge-to-edge repair (TEER) and valve replacement for tricuspid regurgitation. This session highlights how real-time, high-resolution imaging enhances procedural efficiency and safety, reducing reliance on general anesthesia and shortening procedure times compared to traditional imaging modalities.

Beyond visualisation:

Managing life-threatening TAVI complications

19 May 2026 – From EuroPCR 2026

Manage life-threatening complications in TAVI procedures with a structured algorithm for identification and resolution. This session shares expert tips for handling specific severe complications and reviews best practices aimed at complication avoidance to enhance patient safety and procedural success.

Managing life-threatening TAVI complications

Where to leave less behind: non-invasive CT and angiography-derived physiology for DCB lesion selection

20 May 2026 – From EuroPCR 2026

This session elucidates the role of non-invasive coronary CT and angiography-derived physiology in guiding lesion selection for drug-eluting balloon PCI. It emphasises integrating anatomical and physiological data to refine lesion preparation, strategy, and validation beyond angiography, and identifies scenarios where DEB PCI may not be optimal,...

Where to leave less behind: non-invasive CT and angiography-derived physiology for DCB lesion selection

Reshaping what's possible in complex PCI with advanced sirolimus technology

21 May 2026 – From EuroPCR 2026

Focused on advancing complex PCI, this session explores strategies to minimise metal use through advanced sirolimus technologies and drug-coated balloon (DCB) therapies. It highlights the biological and pharmacokinetic characteristics of DCBs, key device design considerations, and practical approaches to less-metal PCI. Clinical cases illustrate challenges such...

Reshaping what's possible in complex PCI with advanced sirolimus technology

TAVI and coronary artery disease: we need the COMPLETE answer!

19 May 2026 – From EuroPCR 2026

Addressing the intersection of transcatheter aortic valve implantation (TAVI) and coronary artery disease, this session reviews contemporary surgical and interventional literature to elucidate current practices. It underscores the need for a large international randomized controlled trial to provide definitive guidance for managing patients with concomitant aortic...

TAVI and coronary artery disease: we need the COMPLETE answer!

Large-bore venous access and vessel closure: all you need to know

19 May 2026 – From EuroPCR 2026

This session provides a comprehensive guide to large-bore venous access and vessel closure techniques, emphasizing best practices and the advantages of ultrasound-guided suture mediated vessel closure compared to traditional figure-of-eight suture methods. It also addresses strategies to avoid and manage potential complications encountered during these procedures.

Large-bore venous access and vessel closure: all you need to know

Align for the future with structural heart innovations - LIVE case and major trial updates

19 May 2026 – From EuroPCR 2026

Stay abreast of structural heart innovations with expert discussions on best-in-class transcatheter aortic valve implantation (TAVI) practices, including imaging, sizing, and procedural strategies. This session with LIVE case introduces the novel Myval Octapro+ transcatheter heart valve (THV), its design philosophy, and potential clinical benefits, along with...

Align for the future with structural heart innovations - Live case and major trial updates

Left main PCI treatment: how Ultreon 3.0 can improve decision making and achieve optimised outcomes

20 May 2026 – From EuroPCR 2026

This session explores how to optimise left main PCI through the integration of intracoronary imaging and physiology using Ultreon 3.0 software. It highlights how this innovative technology supports decision-making, procedural planning, and stent optimisation to improve outcomes in complex lesion management.

Left main PCI treatment: how Ultreon 3.0 can improve decision making and achieve optimised outcomes

Expanding the horizon - Trials addressing unchartered territories in coronary and structural heart

20 May 2026 – From EuroPCR 2026

New clinical evidence is pushing coronary and structural heart therapy into areas that were previously uncertain or inconsistently defined, with multiple landmark trials now shaping future practice.

Among the studies discussed in this EuroPCR 2026 session, are SORT OUT XII, START YOUNG, BISCUSPID, LANDMARK 2 and RESTORE...

Expanding the horizon - Trials addressing unchartered territories in coronary and structural heart

How can we improve the management of aortic stenosis in 2026?

19 May 2026 – From EuroPCR 2026

As aortic stenosis management continues to evolve, this EuroPCR 2026 session looks ahead to the challenges and opportunities shaping clinical practice in 2026. From implementing the latest guidelines in daily care to refining the timing of intervention, the discussion focuses on how earlier identification and treatment...

How can we improve the management of aortic stenosis in 2026?

From referral to discharge: European consensus on the TAVI care pathway

19 May 2026 – From EuroPCR 2026

Across Europe, TAVI programmes are under increasing pressure from rising demand, capacity limits and referral barriers. This EuroPCR 2026 session presents the European consensus on the TAVI care pathway and explores how data-driven, standardised approaches can optimise the patient journey from referral to discharge.

Bringing together clinicians,...

From referral to discharge: European consensus on the TAVI care pathway

Beyond the horizon - Future of structural heart innovations and PCI

20 May 2026 – From EuroPCR 2026

Structural heart and coronary interventions are expanding rapidly, with innovation increasingly focused on managing complex anatomies and diversifying treatment strategies.

The PRISM-PCI toolkit is introduced as a framework to support decision-making in complex PCI, alongside advances in transcatheter valve therapies spanning mitral, tricuspid and pulmonary interventions, as...

Beyond the horizon - Future of structural heart innovations and PCI

Novelties in epicardial physiology: PPG explained in a simulated environment

20 May 2026 – From EuroPCR 2026

Understanding coronary physiology continues to evolve as new indices aim to refine how epicardial disease is assessed in daily practice.

The perfusion pressure gradient (PPG) index is introduced in this EuroPCR 2026 session as a novel approach to characterising epicardial coronary physiology. Rather than relying solely on...

Novelties in epicardial physiology: PPG explained in a simulated environment
Didn’t find what you were looking for?